Aaron Wealth Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207K Buy
+2,959
New +$153K 0.01% 674
2022
Q2
Sell
-56,329
Closed -$327K 591
2022
Q1
$327K Buy
+56,329
New +$9.48M ﹤0.01% 639

Other funds holding MRNA

Aaron Wealth Advisors's MRNA Position: Q2 2026 in Review

Aaron Wealth Advisors opened a new position in Moderna (MRNA) in Q2 2026: 2,959 shares worth $207K. The stake represents 0.01% of the portfolio and ranks #674 among its holdings. This is a return to the name: Aaron Wealth Advisors previously reported a position in MRNA as recently as Q1 2022.

Aaron Wealth Advisors first reported a position in MRNA in Q1 2022 and has held it in 2 quarters since. The position peaked at $327K in Q1 2022. 118 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Aaron Wealth Advisors held 2,959 shares of Moderna worth $207K as of Q2 2026.
  • Moderna was a new Aaron Wealth Advisors position in Q2 2026.
  • Moderna made up 0.01% of Aaron Wealth Advisors's portfolio in Q2 2026, its #674 holding.
  • Aaron Wealth Advisors first reported a position in Moderna in Q1 2022 and has held it in 2 quarters since.
  • Aaron Wealth Advisors's Moderna position peaked at $327K in Q1 2022.
  • 118 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.